Black Diamond Therapeutics Inc. (BDTX) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Black Diamond Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Black Diamond Therapeutics Inc. (BDTX) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $101M. It trades at $1.83, up 4.57% today. Its overall quality score is 51 out of 100, ranked against the whole US market. 7 analysts' average target of $10.33 implies +464.5% from today's price. Kronos AI's 30-day forecast is +5.4% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.33 |
| Low – high | $8.00 – $14.00 |
| Analysts | 7 |
| Upside to average | +464.5% |
Kronos AI 30-day forecast
| Expected close | $1.84 (+5.4%) |
| Likely range | +2.5% … +22.0% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 41 |
| Solvency | 56 |
| Growth | 55 |
| Overall | 51 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator